In cases of emerging viral pathogens like SARS-CoV-2, the virus that causes COVID-19, Health Canada utilizes the Broad Spectrum Virucide claim to determine the expected efficacy of a disinfectant against an emerging virus.
The SHYIELD™ line of disinfectants (concentrate, ready-to-use and premoistened wipes) have broad-spectrum virucidal efficacy, as well as demonstrated effectiveness against viruses similar to SARS-CoV-2 on hard, non-porous surfaces. For this reason, the SHYIELD line of disinfectants are included on Health Canada’s list of approved disinfectants to be used against SARS-CoV-2 as part of a facility’s COVID-19 infection prevention and control plan.
For further information, please review our research highlights document below:
